Scientists at Oxford University have released more data that confirm coronavirus vaccines made by Pfizer-BioNTech and AstraZeneca both significantly cut the risk of infection after a single dose.
In studies published on Friday, researchers said there was no apparent difference in the vaccines' ability to reduce COVID-19 infection rates.
The research has not yet been published in a peer-reviewed journal but is based on data from nose and throat swabs taken from more than 370,000 participants in England and Wales between December and April.
The scientists said that three weeks after people had been given a single dose of either the Pfizer-BioNTech or AstraZeneca vaccine, the rates of all COVID-19 infections fell by 65 per cent. The reduction was bigger after a second dose and the vaccines appeared to protect people against the variant that was first identified in the UK.
Dr. Koen Pouwels, a senior researcher at Oxford University, noted there was some evidence of vaccinated people catching COVID-19 and that there was some limited spread of the disease from people who had been immunised.
This emphasises the need for everyone to continue to follow guidelines to reduce transmission risk, for example through social distancing and masks, Pouwels said in a statement.
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU